Adage Capital Partners’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-31,000
| Closed | -$1.6M | – | 918 |
|
|
2022
Q4 | $1.6M | Buy |
+31,000
| New | +$1.6M | ﹤0.01% | 823 |
|
|
2022
Q3 | – | Sell |
-460,000
| Closed | -$20.8M | – | 1049 |
|
|
2022
Q2 | $20.8M | Buy |
460,000
+135,000
| +42% | +$6.1M | 0.05% | 409 |
|
|
2022
Q1 | $16.5M | Buy |
+325,000
| New | +$16.5M | 0.03% | 551 |
|
|
2020
Q1 | – | Sell |
-100,000
| Closed | -$3.06M | – | 729 |
|
|
2019
Q4 | $3.06M | Sell |
100,000
-400,000
| -80% | -$12.2M | 0.01% | 645 |
|
|
2019
Q3 | $12M | Hold |
500,000
| – | – | 0.03% | 481 |
|
|
2019
Q2 | $12.7M | Hold |
500,000
| – | – | 0.03% | 482 |
|
|
2019
Q1 | $9.75M | Hold |
500,000
| – | – | 0.02% | 530 |
|
|
2018
Q4 | $6.6M | Buy |
500,000
+281,000
| +128% | +$3.71M | 0.02% | 576 |
|
|
2018
Q3 | $3.89M | Sell |
219,000
-62,000
| -22% | -$1.1M | 0.01% | 651 |
|
|
2018
Q2 | $6.18M | Buy |
+281,000
| New | +$6.18M | 0.01% | 636 |
|